Recent Activity
-
May 7
This week Richard discusses a study on remeasuring CV risk in untreated people at low and intermediate risk.
-
May 6
Although elective PCI for most low-risk patients is extremely safe, overnight observation is still standard practice in the U.S., largely due to the l... -
May 3 The FDA has approved a new combination drug from Merck for lowering cholesterol. The drug, which will carry the brand name of Liptruzet, is a combinat...
-
May 2 A large observational study found no increased risk for cardiovascular events associated with azithromycin (Zithromax, Pfizer) in a general population...
-
May 1 The FDA has issued a drug safety communication concerning tolvaptan (Samsca, Otsuka), a selective vasopression V2-receptor antagonist used in heart fa...
-
May 1
Offer your diagnosis of a 39-year-old man with severe pulmonary hypertension and markedly variable pulmonary capillary wedge pressures among lung segments.
-
Apr 30 Here are two small but important changes in the anticoagulation field: FDA approves new product for urgent reversal of anticoagulation. The FDA yester...
-
Apr 30
Cardiology is now standardized and guideline-based. We have algorithms for everything. Is there any room left for thinking?
-
Apr 29 Using an unconventional mathematical approach, a group of Japanese researchers say there may be no good reason to reduce LDL cholesterol more than 40 ...
-
Apr 29
This week’s topics include the association of perioperative beta-blockade with mortality and CV morbidity following major noncardiac surgery, intestinal microbial metabolism of phosphatidylcholine and CV risk, and more.
-
Apr 29
From the ISHLT meeting in Montreal, Bill Cornwell shares highlights of the plenary address from Jack G. Copeland, M.D., this year’s recipient of the Pioneer in Transplantation award.
-
Apr 26 Two new trials have ended up reporting conflicting results regarding the expansion of the indication for cardiac resynchronization therapy (CRT) for p...
-
Apr 25 A new study from the Cleveland Clinic research group headed by Stanley Hazen offers more evidence in support of the hypothesis that TMAO (trimethylami...
-
Apr 25
Recently in the Journal of the American College of Cardiology Viskin et al published the results of a survey looking at the worldwide availability of... -
Apr 24
In a study recently published online by JACC, investigators assess the association between natriuretic peptide levels and body-fat distribution. Ian Neeland, the lead author of the study, responds to John Ryan’s questions.
-
Apr 24 Patients with atrioventricular (AV) block generally receive right ventricular (RV) pacing; cardiac resynchronization therapy (CRT) has been restricted...
-
Apr 23 The use of perioperative beta-blockade for noncardiac surgery has been declining as a result of the controversial POISE study, which turned up evidenc...
-
Apr 22
This week’s topics include the prevalence of a healthy lifestyle among those with CV disease in high-, middle-, and low-income countries, nonemergency PCI at hospitals with or without on-site cardiac surgery, and coronary artery calcium score prediction of all-cause mortality and CV events in those with type-2 diabetes.
-
Apr 22 Shalom "Shal" Jacobovitz will be the new chief executive officer of the American College of Cardiology, the ACC announced today. Jacobovitz is current...
-
Apr 22 In recent years the FDA has come under increasing fire for approving drugs on the basis of surrogate endpoints without any evidence of greater clinica...
Sandeep Goyal shares his experience at the Heart Rhythm Society meeting in Denver: 
